| Value | ₹0.65 Cr |
|---|---|
| Execution period | By 31-12-2026 |
BSE filing, NSE: MUKKA. Summary written from the filing by ALFA Finder's alert engine.
Mukka Proteins Ltd: key numbers
- Share price
- ₹24.19
- Market cap
- ₹725.7 Cr
- Revenue (annual)
- ₹1,449 Cr
- Net profit (annual)
- ₹52.06 Cr
- P/E (TTM)
- 10.5×Sector 26.2×
- Promoter holding
- 73.33%+0.00% QoQ
- FII holding
- 1.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mukka Proteins Ltd
All →Mukka Proteins Regulatory Approval
Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.
- Execution
- October 1, 2026 to December 31, 2027
Mukka Proteins Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Mukka Proteins Production Started
Mukka Proteins Limited announced its subsidiary, United Gulf Fishery Products LLC, has commenced commercial production in Oman. The facility will produce fish meal and oil.
Mukka Proteins Debt & Borrowing: ₹73.58 Cr
Mukka Proteins Limited approved a corporate guarantee and SBLC worth Rs. 73.58 Crore for its subsidiary in Oman. The security supports credit facilities from HDFC Bank.
- Value
- ₹73.58 Cr
Mukka Proteins Credit Rating
CARE Ratings has reaffirmed the credit ratings of Mukka Proteins Ltd at CARE BBB-; Stable / CARE A3.
Mukka Proteins Credit Rating
CARE Ratings reaffirmed the credit ratings for Mukka Proteins Ltd's bank facilities totaling ₹495 Crore and revised the outlook from Negative to Stable.
- Value
- ₹495.0 Cr
Other merger & restructuring announcements
All →Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr
Vraj Iron & Steel Merger & Restructuring Worth ₹4.55 Cr
Vraj Iron and Steel transferred 396,000 MVK Industries shares to promoter Gopal Sponge for Rs 4.55 Crore. The sale was completed on October 28, 2026.
- Value
- ₹4.55 Cr
KPIT Technologies Merger & Restructuring Worth ₹19.2 Cr
KPIT Technologies will incorporate a new Vietnam subsidiary for mobility engineering, with 100% control. The company commits USD 2 million (about Rs 19.20 Crore) in cash.
- Value
- ₹19.20 Cr